検索結果

で失明の主 な原因となっています 8。日本では、約 10 万人が罹患していると推定されており、これまでに承認された治療法はありません でした 2,3。 参考文献 1 Boyer DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the comp...

临床试验信息 | 研究与开发 | 千寿制药株式会社

clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica

clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica

clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...

产品开发方针 | 研究与开发 | 千寿制药株式会社

发，从而为患者带去希望。  #1: 井上 佐智子, 川岛 素子, 坪田 一男：什么是干眼症？从原因到最新的治疗，Farumashia，2014 50(3): 201-6  #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-6...